Avivagen Inc. VIVXF
VIVXF Rating
VIVXF Rating Factors
VIVXF Company Overview
Avivagen Inc. is a Canada-based life sciences and animal health company focused on developing and commercializing products intended to support livestock health and productivity without relying on antibiotics. The company operates primarily in the animal nutrition and feed additive industry, with a strategic emphasis on products designed to promote animal performance, immune function, and food production efficiency. Avivagen’s principal commercial platform is its proprietary oxidized beta-carotene technology marketed under the OxC-beta brand, which is incorporated into feed formulations for poultry, swine, and dairy cattle production.
The company’s primary revenue drivers are sales of OxC-beta feed additive products through commercial distribution partnerships and direct relationships in agricultural markets. Avivagen has historically focused on regions with large-scale livestock industries, including parts of Asia, North America, and Latin America. The company evolved from earlier biotechnology and nutraceutical activities into a more concentrated animal health and feed technology business, aligning its strategy with global efforts to reduce antibiotic use in food-producing animals while maintaining herd and flock productivity.
VIVXF Income Statement
VIVXF Balance Sheet
VIVXF Price History
- Current
- $0.00
VIVXF Valuation
VIVXF Dividends and Shares
VIVXF Corporate Info
Ottawa, ON K1A 0R6